Furthermore, a recent study suggested a novel function of mTOR complex 2 (mTORC2) in NADPH oxidase-dependent ROS production and podocyte apoptosis that mediates disruption of podocyte integrity and albuminuria in type 1 diabetes [20]. Here, FMO5 is linked to type 1 diabetes mellitus.